|Day's Range||76.58 - 77.69|
|52 Week Range||56.59 - 79.63|
|PE Ratio (TTM)||33.94|
|Dividend & Yield||1.32 (1.70%)|
|1y Target Est||N/A|
Currency headwind is likely to dampen ResMed's (RMD) gains in the COPD and sleep apnea market.
California-based ResMed, Inc. (RMD) has been on a healthy growth trajectory of late.
On Jul 6, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD).